BCL2 and B-cell non-Hodgkin lymphoma: Further characterisation of high-grade B-cell lymphoma achieved by next-generation sequencing, and mutations of MYC and BCL2 and/or BCL6 genes (“double-hit”-DHIT or “triple-hit”-THIT lymphoma) have been associated in various studies with a worse prognosis [1,2,13].